Skip to main content

IDWeek 2023 Main banner

Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

266 Views

043. Clinical Trials: Thursday, 12:15 - 1:30 p.m.

Poster Session: Clinical Trials

(363) A Phase II Prospective Randomized Study to Assess Imipenem-Relebactam in the Management of Cancer Patients with Febrile Neutropenia

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Virtual

Presenting Author(s)

Anne-Marie Chaftari, MD

Associate Professor
MD Anderson UT
Houston, Texas, United States

Co-Author(s)

HD

Hiba Dagher, MD (she/her/hers)

Postdoctoral Fellow
UT MD Anderson Cancer Center
Houston, Texas, United States
Ray Y. Hachem, MD, PhD

Professor
MD Anderson UT
Houston, Texas, United States
YJ

Ying Jiang, MS

Research Statistical Analyst
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
PL

Peter Lamie, DO

UT MD Anderson Cancer Center
Houston, Texas, United States
RW

Rita Wilson Dib, MD

MD Anderson Cancer Center
Houston, Texas, United States
TJ

Teny John, MD

MD Anderson Cancer Center
Houston, Texas, United States
Andrea Haddad, MD

Postdoctoral Research Fellow
UT MD Anderson Cancer Center
houston, Texas, United States
AP

Ann Philip, RN

MD Anderson Cancer Center
Houston, Texas, United States
SA

Shahnoor Ali, RN

MD Anderson Cancer Center
Houston, Texas, United States
PM

Patricia Mulanovich, n/a

MD Anderson Cancer Center
Houston, Texas, United States
YJ

Ying Juan, MD

MD Anderson Cancer Center
Houston, Texas, United States
PC

Patrick Chaftari, MD

Associate Professor
UT MDAnderson Cancer Center
Houston, TX, United States
IR

Issam I. Raad, Distinguished Professor

Professor
MD Anderson UT
Houston, Texas, United States